Brazil's 3D Imaging market is projected to grow from $0.76 Bn in 2022 to $2.76 Bn by 2030, registering a CAGR of 17.5% during the forecast period of 2022-30. The market will be driven by advancements in technology, increased investment, and the growing demand for more accurate and non-invasive diagnostic tools. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Philips Healthcare & Siemens Healthineers
Brazil's 3D Imaging market is projected to grow from $0.76 Bn in 2022 to $2.76 Bn by 2030, registering a CAGR of 17.5% during the forecast period of 2022-30. According to the World Health Organization's Global Health Expenditure database, Brazil's current health expenditure (as a percentage of GDP) increased from 9.46% in 2018 to 9.59% in 2019. Brazil's health spending is expected to increase to 12.6% of GDP by 2040, with opportunities for improvement in areas such as primary health care, hospital care, medications, long-term care, and governance. Brazil has taken steps to close the gap and improve healthcare coverage and access. According to The Global Cancer Observatory 2020, out of a total population of 212.55 Mn, the number of new cases of cancer was 0.592 Mn with 0.26 Mn deaths. CVDs are the leading cause of mortality in Brazil and their prevalence contributes to 6.1% of the population, according to both the GDB Study 2019 and the SUS database.
In Brazil, 3D imaging is a fast-expanding sector that is utilized by healthcare practitioners to diagnose and treat a wide range of medical issues. CT scans, MRI scans, and PET scans are some of the most popular applications of 3D imaging in Brazil. These imaging technologies provide very detailed pictures of the human body, enabling clinicians to discover and comprehend complicated medical issues. The number of 3D imaging centers in Brazil has increased significantly in recent years, indicating the rising demand for these services among patients and healthcare practitioners. Many of these facilities are outfitted with cutting-edge imaging technology and overseen by highly skilled technicians and radiologists.
In January 2023, Lunit, a South Korean business, signed a three-year agreement to deliver its AI imaging solution to one of Brazil's leading hospitals. The AI chest x-ray image processing program "Lunit INSIGHT CXR" will be applied at Hospital Israelita Albert Einstein, which operates 22 private hospitals and 29 public health institutions.
Market Growth Drivers
Medical imaging technological developments have made 3D imaging more accessible and inexpensive, resulting in its broad adoption in Brazil. Moreover, improved patient outcomes have led to an increase in the adoption of the same. The Brazilian government has taken many measures to promote access to medical imaging services, such as expanding imaging facilities and educating more specialists in the area. The expansion of the Brazilian healthcare industry is also contributing to the expansion of 3D imaging. The need for improved medical imaging technology grows in tandem with the demand for healthcare services.
Market Restraints
Despite the rising demand for specialized diagnostic imaging technologies in Brazil, the 3D medical imaging industry is being held back by a number of issues. One significant impediment is the lack of access to healthcare services and specialized medical equipment in rural and underserved areas. As a result, 3D imaging technologies are less widely used, and the market for these systems is smaller. Furthermore, the high cost of 3D imaging equipment, as well as the requirement for specialized training and infrastructure to operate them, offer substantial financial hurdles to healthcare practitioners and institutions, particularly in the public sector. Complex rules and licensing requirements for medical equipment often create hurdles to competition for new market participants.
Key Players
The Brazilian National Health Surveillance Agency (ANVISA) oversees the import and marketing of medical equipment, including 3D imaging systems, to ensure its safety and efficacy. In order to minimize the level of radiation that individuals and health professionals are exposed to, the Ministry of Health also creates standards for the use of radiation in medical imaging. Furthermore, the Brazilian College of Radiology and Diagnostic Imaging (CBR) develops guidelines for imaging exam interpretation and documentation, ensuring that the results are accurate and reliable.
In Brazil, the country's public healthcare system, known as the Unified Health System The Sistema Único de Saúde (SUS), is largely responsible for reimbursement for 3D imaging. SUS is a universal, publicly financed healthcare system that offers healthcare services to all Brazilian citizens and permanent residents, regardless of capacity to pay.
SUS reimburses medical imaging services, including 3D imaging, in accordance with the Brazilian Medical Code and other ANVISA (National Health Surveillance Agency) requirements. The payment for 3D imaging services is designed to cover the cost of the operation as well as associated services such as radiologist interpretation of pictures.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Product (Revenue, USD Billion):
The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.
By Application (Revenue, USD Billion):
The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.
By End User (Revenue, USD Billion):
Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.
By Portability (Revenue, USD Billion):
The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.